#VU26245 Improper access control in Omnipod Insulin Management System - CVE-2020-10597 

 

#VU26245 Improper access control in Omnipod Insulin Management System - CVE-2020-10597

Published: March 20, 2020


Vulnerability identifier: #VU26245
Vulnerability risk: Low
CVSSv4.0: CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:U/U:Clear
CVE-ID: CVE-2020-10597
CWE-ID: CWE-284
Exploitation vector: Local access
Exploit availability: No public exploit available
Vulnerable software:
Omnipod Insulin Management System
Software vendor:
Insulet Corporation

Description

The vulnerability allows a local attacker to gain unauthorized access to otherwise restricted functionality.

The vulnerability exists due to improper access restrictions in the wireless RF communication protocol. A local attacker with access to one of the affected insulin pump models can bypass implemented security restrictions and modify and/or intercept data.

The vulnerability can also allow attackers to change pump settings and control insulin delivery.

This vulnerability affects the following versions of the Omnipod Insulin Management System:

  • Product ID/Reorder number: 19191 and 40160
  • UDI/Model/NDC number: ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)

  • Remediation

    Cybersecurity Help is currently unaware of any official solution to address this vulnerability.

    External links